Ambu A/S (OTCMKTS:AMBBY) Sees Large Volume Increase – Here’s What Happened

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBYGet Free Report) saw strong trading volume on Wednesday . 3,200 shares changed hands during mid-day trading, an increase of 330% from the previous session’s volume of 744 shares.The stock last traded at $13.82 and had previously closed at $13.20.

Ambu A/S Stock Up 4.7%

The company has a market cap of $3.25 billion, a P/E ratio of 40.65 and a beta of 0.93. The company’s 50-day moving average is $13.61 and its two-hundred day moving average is $14.55. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.72 and a quick ratio of 1.63.

Ambu A/S (OTCMKTS:AMBBYGet Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 10.00% and a return on equity of 10.35%.

About Ambu A/S

(Get Free Report)

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

See Also

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.